Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

References for PMC Articles for PubMed (Select 22131357)

1.

Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes.

Lewis GD, Murphy RM, Shah RV, Pappagianopoulos PP, Malhotra R, Bloch KD, Systrom DM, Semigran MJ.

Circ Heart Fail. 2011 May;4(3):276-85. doi: 10.1161/CIRCHEARTFAILURE.110.959437. Epub 2011 Feb 3.

2.

The arterial load in pulmonary hypertension.

Saouti N, Westerhof N, Postmus PE, Vonk-Noordegraaf A.

Eur Respir Rev. 2010 Sep;19(117):197-203. doi: 10.1183/09059180.00002210. Review.

3.

Right ventricular load at exercise is a cause of persistent exercise limitation in patients with normal resting pulmonary vascular resistance after pulmonary endarterectomy.

Bonderman D, Martischnig AM, Vonbank K, Nikfardjam M, Meyer B, Heinz G, Klepetko W, Naeije R, Lang IM.

Chest. 2011 Jan;139(1):122-7. doi: 10.1378/chest.10-0348. Epub 2010 Jul 29.

PMID:
20671059
4.

Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.

Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM.

Circ Heart Fail. 2010 Sep;3(5):588-95. doi: 10.1161/CIRCHEARTFAILURE.109.930701. Epub 2010 Jun 11.

5.

Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.

Meyer P, Filippatos GS, Ahmed MI, Iskandrian AE, Bittner V, Perry GJ, White M, Aban IB, Mujib M, Dell'Italia LJ, Ahmed A.

Circulation. 2010 Jan 19;121(2):252-8. doi: 10.1161/CIRCULATIONAHA.109.887570. Epub 2010 Jan 4.

6.

RC time constant of single lung equals that of both lungs together: a study in chronic thromboembolic pulmonary hypertension.

Saouti N, Westerhof N, Helderman F, Marcus JT, Stergiopulos N, Westerhof BE, Boonstra A, Postmus PE, Vonk-Noordegraaf A.

Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2154-60. doi: 10.1152/ajpheart.00694.2009. Epub 2009 Oct 2.

7.

Surrogate and combined end points in pulmonary arterial hypertension.

Ventetuolo CE, Benza RL, Peacock AJ, Zamanian RT, Badesch DB, Kawut SM.

Proc Am Thorac Soc. 2008 Jul 15;5(5):617-22. doi: 10.1513/pats.200803-029SK. Review.

PMID:
18625754
8.

Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension.

Lankhaar JW, Westerhof N, Faes TJ, Gan CT, Marques KM, Boonstra A, van den Berg FG, Postmus PE, Vonk-Noordegraaf A.

Eur Heart J. 2008 Jul;29(13):1688-95. doi: 10.1093/eurheartj/ehn103. Epub 2008 Mar 17.

9.

Right ventricular dysfunction as an independent predictor of short- and long-term mortality in patients with heart failure.

Kjaergaard J, Akkan D, Iversen KK, Køber L, Torp-Pedersen C, Hassager C.

Eur J Heart Fail. 2007 Jun-Jul;9(6-7):610-6. Epub 2007 Apr 25.

PMID:
17462946
10.

Tricuspid annular displacement predicts survival in pulmonary hypertension.

Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, Chamera E, Corretti MC, Champion HC, Abraham TP, Girgis RE, Hassoun PM.

Am J Respir Crit Care Med. 2006 Nov 1;174(9):1034-41. Epub 2006 Aug 3.

PMID:
16888289
11.

Quantification of right ventricular afterload in patients with and without pulmonary hypertension.

Lankhaar JW, Westerhof N, Faes TJ, Marques KM, Marcus JT, Postmus PE, Vonk-Noordegraaf A.

Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1731-7. Epub 2006 May 12.

12.

Sildenafil citrate therapy for pulmonary arterial hypertension.

Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G; Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group.

N Engl J Med. 2005 Nov 17;353(20):2148-57. Erratum in: N Engl J Med. 2006 Jun 1;354(22):2400-1.

13.

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, Keogh A, Oudiz R, Frost A, Blackburn SD, Crow JW, Rubin LJ; Treprostinil Study Group.

Am J Respir Crit Care Med. 2002 Mar 15;165(6):800-4.

PMID:
11897647
14.

Use of pulse pressure method for estimating total arterial compliance in vivo.

Stergiopulos N, Segers P, Westerhof N.

Am J Physiol. 1999 Feb;276(2 Pt 2):H424-8.

15.

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.

Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Clayton LM, Jöbsis MM, Blackburn SD, Shortino D, Crow JW; Primary Pulmonary Hypertension Study Group.

N Engl J Med. 1996 Feb 1;334(5):296-301.

16.

Evaluation of methods for estimation of total arterial compliance.

Stergiopulos N, Meister JJ, Westerhof N.

Am J Physiol. 1995 Apr;268(4 Pt 2):H1540-8.

PMID:
7733355
17.

Age-related changes in the mechanics of the aorta and pulmonary artery of man.

Gozna ER, Marble AE, Shaw A, Holland JG.

J Appl Physiol. 1974 Apr;36(4):407-11. No abstract available.

PMID:
4820321
18.

Isolated aorta setup for hemodynamic studies.

Sipkema P, Latham RD, Westerhof N, Rubal BJ, Slife DM.

Ann Biomed Eng. 1990;18(5):491-503.

PMID:
2240712
19.

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, et al.

Ann Intern Med. 1991 Sep 1;115(5):343-9.

PMID:
1863023
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk